Organization Overview
Alternative names
aliskiren (tekturna) (1 trial)
capmatinib (Tabrecta) (1 trial)
ceftaroline fosamil (teflaro) (2 trials)
fondaparinux sodium (arixtra) (2 trials)
fosamprenavir (lexiva) (1 trial)
ivabradine (corlanor) (1 trial)
lamivudine (epivir) (2 trials)
aldesleukin (Proleukin) (10 trials)
autologous mononuclear stem cell (2 trials)
beractant (survanta) (1 trial)
bortezomib (velcade) (10 trials)
cetuximab (erbitux) (2 trials)
ciprofloxacin (cipro) (1 trial)
cisplatin (platinol) (13 trials)
colfosceril palmitate (1 trial)
darolutamide (Nubeqa) (1 trial)
enzalutamide (xtandi) (2 trials)
fluorouracil (efudex) (5 trials)
follitropin alfa (Gonal-F) (1 trial)
gemcitabine (gemzar) (18 trials)
goserelin (zoladex) (2 trials)
human factor ix complex (prothrombin complex concentrate) (Bebulin) (1 trial)
hydroxyurea (hydrea) (3 trials)
immune globulin (human) (Gamastan) (1 trial)
indomethacin (indocin) (1 trial)
interferon alpha-2b (Intron-A) (4 trials)
leuprolide (lupron) (2 trials)
levofloxacin (levaquin) (1 trial)
metformin (glucophage) (1 trial)
metronidazole (flagyl) (2 trials)
nitric oxide (inomax) (3 trials)
paclitaxel (taxol) (12 trials)
phenobarbital (Luminal) (1 trial)
pilocarpine (ocusert) (1 trial)
abiraterone (zytiga) (1 trial)
acetylsalicylic acid (aspirin) (2 trials)
allogeneic bone marrow (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (6 trials)
allogeneic microbiota (1 trial)
alpha-methyltryptophan (1 trial)
alprostadil (prostin) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)
autologous hematopoietic stem cells (6 trials)
autologous lymphocytes (6 trials)
belinostat (beleodaq) (1 trial)
bevacizumab (avastin) (7 trials)
bicalutamide (casodex) (1 trial)
capecitabine (xeloda) (4 trials)
carboplatin (paraplatin) (5 trials)
cyclophosphamide (cytoxan) (12 trials)
cyclosporine (sandimmune) (2 trials)
cytarabine (cytosar-u) (5 trials)
daclizumab (Zenapax) (1 trial)
dasatinib (sprycel) (2 trials)
degarelix acetate (firmagon) (1 trial)
docetaxel (taxotere) (15 trials)
doxorubicin (Doxil) (4 trials)
egfrbi-armed autologous t cells (1 trial)
erlotinib (tarceva) (3 trials)
etoposide (vepesid) (7 trials)
everolimus (zortress) (2 trials)
Filgrastim (neupogen) (1 trial)
hydrocortisone (solu-cortef) (4 trials)
hydromorphone (diladid) (2 trials)
ibrutinib (imbruvica) (1 trial)
irinotecan (Camptosar) (4 trials)
lidocaine (xylocaine) (1 trial)
loncastuximab (Zynlonta) (1 trial)
melphalan (alkeran) (6 trials)
methylprednisolone (medrol) (1 trial)
minocycline (minocin) (1 trial)
mirabegron (myrbetriq) (1 trial)
mirtazapine (remeron) (1 trial)
mrna-1273 (Spikevax) (1 trial)
muromonab cd3 (Orthoclone OKT3) (2 trials)
n-(4-hydroxyphenyl)all-trans retinamide (3 trials)
olanzapine (zyprexa) (1 trial)
oxaliplatin (eloxatin) (4 trials)
pasireotide (signifor) (1 trial)
polatuzumab vedotin (Polivy) (1 trial)
prednisolone (hydeltra) (2 trials)
prednisone (meticorten) (6 trials)
propranolol (inderal) (1 trial)
recombinant adenoviral human p53 gene (1 trial)
regadenoson (lexiscan) (1 trial)
rituximab (rituxan) (3 trials)
spironolactone (aldactone) (1 trial)
sucroferric oxyhydroxide (Venofer) (1 trial)
suvorexant (belsomra) (1 trial)
tamoxifen (nolvadex) (1 trial)
telotristat ethyl (xermelo) (1 trial)
tetracaine (pontocaine) (1 trial)
valaciclovir (Valtrex) (1 trial)
vandetanib (caprelsa) (1 trial)
1-(2-[18f]fluoroethyl)-l-tryptophan (1 trial)
acetylcysteine (mucomyst) (1 trial)
arsenic trioxide (trisenox) (1 trial)
azithromycin (zithromax) (1 trial)
dehydroepiandrosterone (1 trial)
denileukin diftitox (ontak) (1 trial)
egfrbi armed atc infusions (1 trial)
elotuzumab (empliciti) (1 trial)
fludeoxyglucose f-18 (2 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
miconazole (monistat) (1 trial)
octreotide (sandostatin) (1 trial)
palifermin (Kepivance) (1 trial)
pexidartinib (Turallo) (1 trial)
pomalidomide (pomalyst) (1 trial)
ambrisentan (letairis) (1 trial)
amphetamine (Adderall) (1 trial)
autologous umbilical cord blood (1 trial)
bupivacaine (Exparel) (3 trials)
Acne Vulgaris (Phase 3)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 1)
Adenocarcinoma of Lung (Phase 1)
Amyloidosis (Phase 2)
Anemia (Phase 3)
Anemia, Iron-Deficiency (Phase 2)
Anemia, Neonatal (Phase 3)
Anemia, Sickle Cell (Phase 3)
Astrocytoma (Phase 2)
Autistic Disorder (Phase 3)
Autonomic Dysreflexia (Phase 4)
Bacteremia (Phase 3)
Bacterial Infections (Phase 1)
Bile Duct Neoplasms (Phase 2)
Bipolar Disorder (Phase 4)
Birth Weight (Phase 3)
Blood Coagulation Disorders (Phase 3)
Body Weight (Phase 3)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Burkitt Lymphoma (Phase 1)
Carcinoma (Phase 2)
Carcinoma, Acinar Cell (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cellulitis (Phase 4)
Central Nervous System Neoplasms (Phase 3)
Cerebrovascular Disorders (Phase 4)
Charcot-Marie-Tooth Disease (Phase 3)
Cholangiocarcinoma (Phase 2)
Choroid Plexus Neoplasms (Phase 3)
Chronic Pain (Phase 1)
Clostridium Infections (Phase 2)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 4)
Condylomata Acuminata (Phase 4)
Connective Tissue Diseases (Phase 2)
Critical Illness (Phase 4)
Deficiency Diseases (Phase 2)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Depressive Disorder, Major (Phase 3)
Diabetes Mellitus, Type 2 (Phase 1)
Disease (Phase 3)
Ductus Arteriosus, Patent (Phase 3)
Emergencies (Phase 3)
Enterocolitis (Phase 2)
Ependymoma (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fetal Alcohol Spectrum Disorders (Phase 3)
Gallbladder Neoplasms (Phase 2)
Gastroenteritis (Phase 3)
Gastroesophageal Reflux (Phase 3)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Glucose Intolerance (Phase 4)
Graft vs Host Disease (Phase 3)
Head and Neck Neoplasms (Phase 3)
Heart Failure (Phase 4)
Hematologic Diseases (Phase 3)
Hemophilia A (Phase 3)
Hemorrhage (Phase 3)
Hemorrhagic Disorders (Phase 3)
Hemostatic Disorders (Phase 3)
Hereditary Sensory and Motor Neuropathy (Phase 3)
Heroin Dependence (Phase 1)
Hodgkin Disease (Phase 2)
Hyperpigmentation (Phase 3)
Hypersensitivity (Phase 2)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 3)
Hypotension (Phase 1)
Immunoblastic Lymphadenopathy (Phase 1)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Infant, Newborn, Diseases (Phase 3)
Infections (Phase 4)
Infertility (Phase 3)
Inflammatory Bowel Diseases (Phase 2)
Insulin Resistance (Phase 3)
Intestinal Diseases (Phase 2)
Intraabdominal Infections (Phase 3)
Intracranial Hemorrhages (Phase 3)
Ischemic Attack, Transient (Phase 4)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, T-Cell (Phase 1)
Liver Diseases (Phase 1)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 1)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 1)
Lymphoproliferative Disorders (Phase 2)
Malignant Carcinoid Syndrome (Phase 2)
Marijuana Abuse (Phase 1)
Medulloblastoma (Phase 3)
Melanoma (Phase 3)
Meningioma (Phase 2)
Mesothelioma (Phase 2)
Metabolic Syndrome (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 3)
Multiple Pulmonary Nodules (Phase 1)
Multiple Sclerosis (Phase 3)
Muscle Cramp (Phase 4)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Nerve Compression Syndromes (Phase 3)
Nervous System Neoplasms (Phase 3)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuroectodermal Tumors, Primitive (Phase 3)
Neuroendocrine Tumors (Phase 2)
Oligodendroglioma (Phase 2)
Osteochondrodysplasias (Phase 1)
Osteosarcoma (Phase 3)
Ovarian Neoplasms (Phase 2)
Pain, Postoperative (Phase 4)
Pain, Procedural (Phase 4)
Pancreatic Neoplasms (Phase 3)
Parkinson Disease (Phase 3)
Peritoneal Neoplasms (Phase 1)
Persistent Fetal Circulation Syndrome (Phase 3)
Pinealoma (Phase 3)
Plasmablastic Lymphoma (Phase 1)
Plasmacytoma (Phase 3)
Pneumonia (Phase 3)
Pneumonia, Aspiration (Phase 3)
Pneumonia, Bacterial (Phase 3)
Polycystic Ovary Syndrome (Phase 3)
Precancerous Conditions (Phase 2)
Preleukemia (Phase 2)
Premature Birth (Phase 3)
Prostatic Neoplasms (Phase 3)
Psoriasis (Phase 2)
Psychotic Disorders (Phase 2)
Pulmonary Valve Insufficiency (Phase 3)
Pyelonephritis (Phase 3)
Recurrence (Phase 1)
Renal Insufficiency (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Respiratory Insufficiency (Phase 3)
Retinal Diseases (Phase 3)
Retinoblastoma (Phase 3)
Retinopathy of Prematurity (Phase 3)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Schizophrenia (Phase 2)
Scleroderma, Diffuse (Phase 3)
Scleroderma, Localized (Phase 2)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 3)
Serotonin Syndrome (Phase 2)
Sezary Syndrome (Phase 1)
Shoulder Fractures (Phase 4)
Skin Diseases (Phase 4)
Skin Diseases, Infectious (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Smoldering Multiple Myeloma (Phase 2)
Spasm (Phase 4)
Spasms, Infantile (Phase 4)
Spinal Cord Injuries (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Staphylococcal Skin Infections (Phase 4)
Stomach Neoplasms (Phase 2)
Streptococcal Infections (Phase 2)
Stress Disorders, Post-Traumatic (Phase 4)
Stress Disorders, Traumatic (Phase 2)
Substance-Related Disorders (Phase 2)
Syndrome (Phase 3)
Tendinopathy (Phase 2)
Thromboembolism (Phase 4)
Tinnitus (Phase 2)
Tooth Diseases (Phase 3)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urinary Tract Infections (Phase 3)
Vaginal Diseases (Phase 3)
Vaginosis, Bacterial (Phase 3)
Venous Thromboembolism (Phase 4)
Vesico-Ureteral Reflux (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Warts (Phase 4)
Wilms Tumor (Phase 3)
Wounds and Injuries (Phase 2)